Association of CDH13 genotypes/haplotypes with circulating adiponectin levels, metabolic syndrome, and related metabolic phenotypes: the role of the suppression effect.

PubWeight™: 0.83‹?›

🔗 View Article (PMC 4395292)

Published in PLoS One on April 13, 2015

Authors

Ming-Sheng Teng1, Lung-An Hsu2, Semon Wu3, Yu-Chen Sun4, Shu-Hui Juan5, Yu-Lin Ko6

Author Affiliations

1: Graduate Institute of Medical Sciences, Department of Physiology, College of Medicine, Taipei Medical University, Taipei, Taiwan; Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan.
2: The First Cardiovascular Division, Department of Internal Medicine, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taoyuan, Taiwan.
3: Department of Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan; Department of Life Science, Chinese Culture University, Taipei, Taiwan.
4: Department of Laboratory Medicine, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
5: Graduate Institute of Medical Sciences, Department of Physiology, College of Medicine, Taipei Medical University, Taipei, Taiwan.
6: The Division of Cardiology, Department of Internal Medicine and Cardiovascular Medical Center, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taipei, Taiwan; School of Medicine, Tzu Chi University, Hualien, Taiwan.

Articles cited by this

The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol (1986) 124.55

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation (2005) 43.74

Abdominal obesity and metabolic syndrome. Nature (2006) 14.20

Equivalence of the mediation, confounding and suppression effect. Prev Sci (2000) 13.92

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab (2000) 11.97

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature (2003) 9.79

Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab (2001) 9.53

Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care (2000) 9.10

Plasma adiponectin levels and risk of myocardial infarction in men. JAMA (2004) 7.46

Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions. Nat Med (2007) 5.89

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway. Circulation (2000) 5.36

Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA (2009) 5.08

Can we apply the National Cholesterol Education Program Adult Treatment Panel definition of the metabolic syndrome to Asians? Diabetes Care (2004) 3.87

Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol (2003) 3.78

Inflammation and insulin resistance. FEBS Lett (2007) 3.34

Analysis of mediating variables in prevention and intervention research. NIDA Res Monogr (1994) 2.86

Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes (2007) 1.98

Adiponectin concentrations: a genome-wide association study. Am J Hum Genet (2010) 1.70

T-cadherin is critical for adiponectin-mediated cardioprotection in mice. J Clin Invest (2010) 1.66

Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. Diabetes (2002) 1.63

T-cadherin supports angiogenesis and adiponectin association with the vasculature in a mouse mammary tumor model. Cancer Res (2008) 1.54

Adiponectin: from obesity to cardiovascular disease. Obes Rev (2009) 1.50

Mediation analysis reveals a sex-dependent association between ABO gene variants and TG/HDL-C ratio that is suppressed by sE-selectin level. Atherosclerosis (2013) 1.50

A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes. Diabetes (2011) 1.33

The adiponectin receptors AdipoR1 and AdipoR2 activate ERK1/2 through a Src/Ras-dependent pathway and stimulate cell growth. Biochemistry (2008) 1.23

Genetic architecture of plasma adiponectin overlaps with the genetics of metabolic syndrome-related traits. Diabetes Care (2010) 1.21

CDH13 gene coding T-cadherin influences variations in plasma adiponectin levels in the Japanese population. Hum Mutat (2011) 1.14

Human genetics of adiponectin in the metabolic syndrome. J Mol Med (Berl) (2005) 1.11

Upregulation of adiponectin receptor 1 and 2 mRNA and protein in adipose tissue and adipocytes in insulin-resistant women with polycystic ovary syndrome. Diabetologia (2006) 1.03

Heritability of plasma adiponectin levels and body mass index in twins. J Clin Endocrinol Metab (2007) 0.99

Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice. Biochem Biophys Res Commun (2006) 0.96

Genetic variation in CDH13 is associated with lower plasma adiponectin levels but greater adiponectin sensitivity in East Asian populations. Diabetes (2013) 0.93

A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. Hum Mol Genet (2013) 0.91

C-reactive protein mediates the effect of apolipoprotein E on cytomegalovirus infection. J Infect Dis (2008) 0.89

Genetic and environmental influences on adiponectin, leptin, and BMI among adolescents in Taiwan: a multivariate twin/sibling analysis. Twin Res Hum Genet (2008) 0.87

Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese. Metabolism (2009) 0.84